SAN FRANCISCO, Jan. 13 -- Guidant Corp. shares slipped after the closing
bell Friday as the deadline for the company to choose between two suitors
passed with no word of a deal.
The Nasdaq-100 After Hours Indicator, which tracks the evening action of
the index's leading shares, was last up 0.12 point to 1,746.90.
Over the past week, Guidant has been the target of increasingly
competitive attempts between Boston Scientific Corp. and Johnson & Johnson to
take over the healthcare products maker.
Guidant had until 4 p.m. Eastern time to accept Boston Scientific's
sweetened offer, worth roughly $24.8 billion.
So far none of the companies have issued a statement.
Guidant shares slipped 0.3% to $70.61. Boston Scientific and Johnson &
Johnson shares were active but unchanged at $25.20 and $61.82, respectively.
LSI Industries Inc. shares plummeted more than 1% to $13.50 after the
company lowered its second-quarter earnings outlook to 18 cents to 19 cents a
share on revenue of $73 million.
Analysts polled by Thomson First Call are currently forecasting second-
quarter earnings of 28 cents a share on revenue of $81 million.
AVI BioPharma Inc. shares compounded earlier gains, rising 6% to $5.70.
Earlier, the stock finished 16% higher, fueled by news that the company's
proprietary technology was an effective countermeasure to Ebola infection.
Hansen Natural Corp. shares were among the late session's volume leaders
and extended gains made during the regular session when Citigroup raised its
stock price target to $130 from $88.
The beverage distributor's stock rose 1% to $105.39, building on a 13%
rise during the regular trading session.
Jasmina Kelemen is a MarketWatch reporter based in San Francisco.
This MarketWatch news update is provided to you courtesy of Thomson
Financial. The information herein is believed to be true and accurate. We take
no responsibility for inaccurate information and reserve the right to update
our reports. If you have any questions please e-mail James Sang at
james.sang@thomson.com or call 646.822.6233. For more information about
Thomson Financial visit us at http://www.thomson.com/financial.
SOURCE Thomson Financial Corporate Group